---
title: "招商證券初步數據顯示 2025 年淨利潤同比增長 18.4%"
description: "招商證券：2025 年淨利潤初步增長 18.4% 年比年"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273818398.md"
published_at: "2026-01-27T09:09:07.000Z"
---

# 招商證券初步數據顯示 2025 年淨利潤同比增長 18.4%

> 招商證券：2025 年淨利潤初步增長 18.4% 年比年

招商證券：

-   2025 年初步淨利潤同比增長 18.4%

### Related Stocks

- [600999.CN - 招商證券](https://longbridge.com/zh-HK/quote/600999.CN.md)
- [512000.CN - 華寶中證全指證券公司ETF](https://longbridge.com/zh-HK/quote/512000.CN.md)
- [513750.CN - 廣發中證港股通非銀ETF](https://longbridge.com/zh-HK/quote/513750.CN.md)
- [512070.CN - 易方達滬深300非銀ETF](https://longbridge.com/zh-HK/quote/512070.CN.md)
- [512880.CN - 國泰中證全指證券公司ETF](https://longbridge.com/zh-HK/quote/512880.CN.md)
- [159842.CN - 券商ETF](https://longbridge.com/zh-HK/quote/159842.CN.md)
- [06099.HK - 招商證券](https://longbridge.com/zh-HK/quote/06099.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Standard Chartered FY25 Profit Climbs, Net Interest Income Down | Standard Chartered Plc reported a profit increase in fiscal 2025, with profit before taxation rising to $6.96 billion fr | [Link](https://longbridge.com/zh-HK/news/276689363.md) |
| Huatai Securities platziert Nullkupon-Wandelanleihen über 10 Milliarden HK-Dollar | Huatai Securities Co. Ltd. has announced the successful placement of zero-coupon convertible bonds maturing in 2027, tot | [Link](https://longbridge.com/zh-HK/news/275441638.md) |
| What is an index fund and how does it work? | The whole stock market in one convenient package. | [Link](https://longbridge.com/zh-HK/news/276649984.md) |
| Sekerbank FY Net Profit Up At 2.08 Bln Lira YoY | ŞEKERBANK :SAID ON THURSDAY, FY NET PROFIT OF 2.08 BLN LIRA VERSUS NET PROFIT OF 2.03 BLN LIRA YEAR AGOFY NET INTEREST I | [Link](https://longbridge.com/zh-HK/news/276413881.md) |
| 8 indicators that signal a recession — and how to protect your money | These are the red flags that a recession is coming — or already here. | [Link](https://longbridge.com/zh-HK/news/276445170.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。